Literature DB >> 21521151

Integrating virtual screening and combinatorial chemistry for accelerated drug discovery.

Fabian López-Vallejo1, Thomas Caulfield, Karina Martínez-Mayorga, Marc A Giulianotti, Adel Nefzi, Richard A Houghten, Jose L Medina-Franco.   

Abstract

Virtual screening is increasingly being used in drug discovery programs with a growing number of successful applications. Experimental methodologies developed to speed up the drug discovery processes include high-throughput screening and combinatorial chemistry. The complementarities between computational and experimental screenings have been recognized and reviewed in the literature. Computational methods have also been used in the combinatorial chemistry field, in particular in library design. However, the integration of computational and combinatorial chemistry screenings has been attempted only recently. Combinatorial libraries (experimental or virtual) represent a notable source of chemically related compounds. Advances in combinatorial chemistry and deconvolution strategies, have enabled the rapid exploration of novel and dense regions in the chemical space. The present review is focused on the integration of virtual and experimental screening of combinatorial libraries. Applications of virtual screening to discover novel anticancer agents and our ongoing efforts towards the integration of virtual screening and combinatorial chemistry are also discussed.

Mesh:

Substances:

Year:  2011        PMID: 21521151     DOI: 10.2174/138620711795767866

Source DB:  PubMed          Journal:  Comb Chem High Throughput Screen        ISSN: 1386-2073            Impact factor:   1.339


  29 in total

Review 1.  Shifting from the single to the multitarget paradigm in drug discovery.

Authors:  José L Medina-Franco; Marc A Giulianotti; Gregory S Welmaker; Richard A Houghten
Journal:  Drug Discov Today       Date:  2013-01-20       Impact factor: 7.851

2.  Molecular Modeling and Phenotypic Description of a Patient with a Novel Exonic Deletion of GALNS with Resultant Morquio Syndrome with Two Successful Pregnancies.

Authors:  Pavalan Selvam; Angita Jain; Jessica Abbott; Abhimanyu S Ahuja; Anvir Cheema; Katelyn A Bruno; Herjot Atwal; Irman Forghani; Thomas Caulfield; Paldeep S Atwal
Journal:  Mol Syndromol       Date:  2022-03-09

3.  1,5-Disubstituted Acylated 2-Amino-4,5-dihydroimidazoles as a New Class of Retinoic Acid Receptor-Related Orphan Receptor (ROR) Inhibitors.

Authors:  Maria A Ortiz; F Javier Piedrafita; Adel Nefzi
Journal:  Int J Mol Sci       Date:  2022-04-17       Impact factor: 6.208

4.  Integrating virtual and biochemical screening for protein tyrosine phosphatase inhibitor discovery.

Authors:  Katie R Martin; Pooja Narang; José L Medina-Franco; Nathalie Meurice; Jeffrey P MacKeigan
Journal:  Methods       Date:  2013-08-20       Impact factor: 3.608

5.  Discovery of a Lead Compound for Specific Inhibition of Type I Collagen Production in Fibrosis.

Authors:  Branko Stefanovic; Heather A Michaels; Adel Nefzi
Journal:  ACS Med Chem Lett       Date:  2021-02-24       Impact factor: 4.345

6.  Chemoinformatic analysis of GRAS (Generally Recognized as Safe) flavor chemicals and natural products.

Authors:  José L Medina-Franco; Karina Martínez-Mayorga; Terry L Peppard; Alberto Del Rio
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

7.  Synthetic genetic targeting of genome instability in cancer.

Authors:  Babu V Sajesh; Brent J Guppy; Kirk J McManus
Journal:  Cancers (Basel)       Date:  2013-06-24       Impact factor: 6.639

Review 8.  Molecular modeling of inhibitors of human DNA methyltransferase with a crystal structure: discovery of a novel DNMT1 inhibitor.

Authors:  Jakyung Yoo; Joo Hee Kim; Keith D Robertson; José L Medina-Franco
Journal:  Adv Protein Chem Struct Biol       Date:  2012       Impact factor: 3.507

9.  A peptide & peptide nucleic acid synthesis technology for transporter molecules and theranostics--the SPPS.

Authors:  Ruediger Pipkorn; Klaus Braun; Manfred Wiessler; Waldemar Waldeck; Hans-Hermann Schrenk; Mario Koch; Wolfhard Semmler; Dorde Komljenovic
Journal:  Int J Med Sci       Date:  2014-05-07       Impact factor: 3.738

10.  Identification of a small molecule that selectively inhibits mouse PC2 over mouse PC1/3: a computational and experimental study.

Authors:  Austin B Yongye; Mirella Vivoli; Iris Lindberg; Jon R Appel; Richard A Houghten; Karina Martinez-Mayorga
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.